ArticlePharmaceuticals (Basel, Switzerland)2020
Bioanalytical Assay Development and Validation for the Pharmacokinetic Study of GMC1, a Novel FKBP52 Co-chaperone Inhibitor for Castration Resistant Prostate Cancer.
Oscar Ekpenyong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.